IXENSOR CO., LTD.
Update：2023/06/12
Industries
Main Industry
Health Care
Main Product/Service
1. PixoTestR POCT COVID-19 Antigen Test
2. PixoTestR Blood Glucose Monitoring System
3. PixoTestR POCT System for HbA1c, Lipid Panel
4. EvelineR Smart Fertility System
5. Eveline‧Care Telehealth Platform
6. PixoTechR Platform
2. PixoTestR Blood Glucose Monitoring System
3. PixoTestR POCT System for HbA1c, Lipid Panel
4. EvelineR Smart Fertility System
5. Eveline‧Care Telehealth Platform
6. PixoTechR Platform
Founded Year
2012
Unified Business No.
53927676
Status
Active
Number of Employees
35
Total Paid-in
Capital
306,231,640 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Exclusive content for members
Members-only content. Please log in to access.
Introduction
iXensor is the global pioneer of mobile health.
We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTestR, our first product, is also the world's first FDA approved smartphone camera-based blood test dated back in 2017.
Founded at StanfordUniversity, Palo Alto, and incorporated in Taipei, Taiwan, in 2012, our international team combines expertise in medical engineering, biochemistry, and information technology to develop innovative health-tech products and digital health solutions that empower the connected healthcare of tomorrow.
Our product lines cover Women’s Health, Chronic, and Infectious Diseases are all powered by our core technology - PixoTechR platform. It serves as our engine for the next phase of growth.
We have received many international awards for our innovation, and our business has also been accelerated by Merck Accelerator, Plug & Play’s Creasphere, and Johnson & Johnson Innovation’s JLABs.
We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTestR, our first product, is also the world's first FDA approved smartphone camera-based blood test dated back in 2017.
Founded at StanfordUniversity, Palo Alto, and incorporated in Taipei, Taiwan, in 2012, our international team combines expertise in medical engineering, biochemistry, and information technology to develop innovative health-tech products and digital health solutions that empower the connected healthcare of tomorrow.
Our product lines cover Women’s Health, Chronic, and Infectious Diseases are all powered by our core technology - PixoTechR platform. It serves as our engine for the next phase of growth.
We have received many international awards for our innovation, and our business has also been accelerated by Merck Accelerator, Plug & Play’s Creasphere, and Johnson & Johnson Innovation’s JLABs.
